Biocon Ltd.

₹392.8

+ 4.55 (1.17%)

04:01 pm - close price

BSE: BIOCON

NSE: BIOCON

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 8.44Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.44Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 7.43Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.03Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 30.33Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 8.44Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.44Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 7.43Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.03Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 30.33Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	3422.60	3462.30	3953.70	3917.10	3432.90
Expenditure+	2708.20	2720.70	3026.90	3001.20	2812.50
Other Income+	93.50	157.90	565.50	48.60	1134.50
Operating Profit	714.40	741.60	926.80	915.90	620.40
Interest	233.00	247.70	266.70	227.00	236.00
Depreciation and Amortization	358.00	389.30	414.50	407.00	405.40
Profit Before Tax	183.70	214.30	808.20	319.00	1145.50
Tax+	34.80	41.60	54.90	96.10	283.70
Net Profit	148.90	172.70	753.30	222.90	861.80

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	71431.00	81840.00	111742.00	147557.00	152617.00
Operational Expenses+	58410.00	66914.00	90547.00	115590.00	122430.00
Operating Profit	13021.00	14926.00	21195.00	31967.00	30187.00
Other Income	6052.00	6903.00	7681.00	9675.00	13558.00
OPM %	18.23	18.24	18.97	21.66	19.78
Depreciation and Amortisation	7151.00	8142.00	11131.00	15688.00	16870.00
Interest	577.00	676.00	4190.00	9744.00	8974.00
Profit Before Tax	10677.00	9831.00	8971.00	15252.00	18866.00
Tax	2474.00	1880.00	1553.00	3048.00	4018.00
Net Profit	7405.00	6484.00	4627.00	10225.00	10133.00

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	182146.00	201007.00	517418.00	557534.00	585396.00
Liabilities+	182146.00	201007.00	517418.00	557534.00	585396.00

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	11597.00	11766.00	18525.00	29539.00	40612.00
Cash from Investing Activity	-36247.00	-16991.00	-142818.00	-10045.00	-2341.00
Cash from Financing Activity	25640.00	2421.00	130487.00	-23327.00	-18540.00
Net Cash Flow	990.00	-2804.00	6194.00	-3833.00	19731.00
Opening Cash & Cash Equivalents	8247.00	8970.00	6537.00	12999.00	9195.00
Closing Cash & Cash Equivalents	8970.00	6537.00	12948.00	9195.00	29238.00

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	54.45	54.45	60.64	60.64	60.64	60.64	60.64	60.64	60.64	60.64
Public+	45.55	45.55	39.36	39.36	39.36	39.36	39.36	39.36	39.36	39.36
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	413191	428131	424297	427705	439503	443513	470261	434339	415046	412441

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	71431.00	81840.00	111742.00	147557.00	152617.00
Operational Expenses+	58410.00	66914.00	90547.00	115590.00	122430.00
Operating Profit	13021.00	14926.00	21195.00	31967.00	30187.00
Other Income	6052.00	6903.00	7681.00	9675.00	13558.00
OPM %	18.23	18.24	18.97	21.66	19.78
Depreciation and Amortisation	7151.00	8142.00	11131.00	15688.00	16870.00
Interest	577.00	676.00	4190.00	9744.00	8974.00
Profit Before Tax	10677.00	9831.00	8971.00	15252.00	18866.00
Tax	2474.00	1880.00	1553.00	3048.00	4018.00
Net Profit	7405.00	6484.00	4627.00	10225.00	10133.00

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	11597.00	11766.00	18525.00	29539.00	40612.00
Cash from Investing Activity	-36247.00	-16991.00	-142818.00	-10045.00	-2341.00
Cash from Financing Activity	25640.00	2421.00	130487.00	-23327.00	-18540.00
Net Cash Flow	990.00	-2804.00	6194.00	-3833.00	19731.00
Opening Cash & Cash Equivalents	8247.00	8970.00	6537.00	12999.00	9195.00
Closing Cash & Cash Equivalents	8970.00	6537.00	12948.00	9195.00	29238.00

Ratios

Reported EPS

Bad: 2Current: 8.44Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.44Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 7.43Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.03Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 30.33Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 8.44Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.44Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 7.43Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.03Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 30.33Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	3422.60	3462.30	3953.70	3917.10	3432.90
Expenditure+	2708.20	2720.70	3026.90	3001.20	2812.50
Other Income+	93.50	157.90	565.50	48.60	1134.50
Operating Profit	714.40	741.60	926.80	915.90	620.40
Interest	233.00	247.70	266.70	227.00	236.00
Depreciation and Amortization	358.00	389.30	414.50	407.00	405.40
Profit Before Tax	183.70	214.30	808.20	319.00	1145.50
Tax+	34.80	41.60	54.90	96.10	283.70
Net Profit	148.90	172.70	753.30	222.90	861.80

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	182146.00	201007.00	517418.00	557534.00	585396.00
Liabilities+	182146.00	201007.00	517418.00	557534.00	585396.00

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	54.45	54.45	60.64	60.64	60.64	60.64	60.64	60.64	60.64	60.64
Public+	45.55	45.55	39.36	39.36	39.36	39.36	39.36	39.36	39.36	39.36
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	413191	428131	424297	427705	439503	443513	470261	434339	415046	412441

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Biocon Ltd.

₹392.8

+ 4.55 (1.17%)

04:01 pm - close price

BSE: BIOCON

NSE: BIOCON

Industry: Pharmaceuticals & Drugs

House: Private

Overview